Ariad Pharmaceuticals

13 Biotechs to Watch for at Hematology Conference
Seeking Alpha
Mon, 11/30/09 - 09:32 am
hematology
Allos
ONYX Pharmaceuticals
Facet Biotech
Seattle Genetics
Gentium
Immunogen
Cyclacel
Sunesis
Trubion
Pharmacyclics
Keryx
Aeterna Zentaris
Ariad Pharmaceuticals
Don't Bury Ariad's Patent Yet
Seeking Alpha
Thu, 08/27/09 - 08:15 am
Ariad Pharmaceuticals
Eli Lilly
patents
Ariad Pharmaceuticals initiated at 'Outperform' on prospects for cancer drug, shares rise
Yahoo/AP
Mon, 08/17/09 - 12:55 pm
Ariad Pharmaceuticals
cancer
Ariad Pharmaceuticals: Significant Catalysts Approaching
Seeking Alpha
Fri, 08/14/09 - 09:23 am
Ariad Pharmaceuticals
Merck
Schering Plough
Biotechnology Industry Hits On The Capital Markets
Investopedia
Wed, 08/12/09 - 04:27 pm
MAP Pharmaceuticals
Inspire
Ariad Pharmaceuticals
Micromet
Biotech Discounts Galore
Seeking Alpha
Sun, 08/9/09 - 11:50 am
biotech
RXi Pharmaceuticals
Ariad Pharmaceuticals
Human Genome Sciences
Inspire
MannKind
MAP Pharmaceuticals
Opexa
Transcept
Anesiva
Indenix
Small Cancer Drug Makers Are on Fire
Seeking Alpha
Tue, 08/4/09 - 09:47 am
cancer
Ariad Pharmaceuticals
Oncothyreon
Spectrum Pharmaceuticals
Ariad posts positive early breast cancer test data
Yahoo/AP
Tue, 07/28/09 - 10:49 am
Ariad Pharmaceuticals
breast cancer
Merck
ridaforolimus
Ariad Pharma: Professors Patent Pathways and Possibly Profit?
Seeking Alpha
Thu, 06/18/09 - 09:52 am
Ariad Pharmaceuticals
patents
Ariad's 'Patent' Is Finally, Officially Dead
Seeking Alpha
Fri, 04/10/09 - 08:24 am
Ariad Pharmaceuticals
patents
Eli Lilly
Amgen
ARIAD Announces Court Rulings Regarding NF-B Patent Lawsuit with Lilly
Yahoo
Sat, 04/4/09 - 10:43 am
Ariad Pharmaceuticals
Eli Lilly
Ariad's partner Merck initiates Phase II lung cancer trial
Pharmaceutical Business Review
Tue, 03/10/09 - 07:32 am
Ariad Pharmaceuticals
Merck
drug trials
lung cancer
deforolimus
12 Stem Cell Stocks - Updated
Seeking Alpha
Mon, 03/9/09 - 10:25 am
stem cells
Alexion
Ariad Pharmaceuticals
Celera
Celgene
Cytori
Dendreon
Geron
Integra Lifesciences Holdings
Invitrogen
Neuralstem
StemCell
Osiris Therapeutics
Ariad to raise $24M through stock offering
bizjournals.com
Sun, 02/22/09 - 10:23 am
Ariad Pharmaceuticals
Why ARIAD Pharmaceuticals Needs an SEC Investigation
Seeking Alpha
Mon, 12/15/08 - 07:37 am
Ariad Pharmaceuticals
SEC

Pages